| Neal Renn Trulock, | |
|
4745 Arapahoe Ave Ste 200, Boulder, CO 80303-1082 | |
| (303) 938-4710 | |
| (303) 541-0807 |
| Full Name | Neal Renn Trulock |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 4745 Arapahoe Ave Ste 200, Boulder, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790289270 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | DR.0070567 (Colorado) | Primary |
| Entity Name | Bethpage Medical Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205074739 PECOS PAC ID: 3375692387 Enrollment ID: O20090522000032 |
News Archive
Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered that the presence and integrity of the opioid growth factor receptor (OGFr), which mediates the inhibitory action of opioid growth factor (OGF) on cell proliferation, is a key to understanding the progression and treatment of human ovarian cancer.
"Once we have found the factors by which body cells can be re-programmed into stem cells, then therapeutic cloning might become superfluous," said Hans R. Scholer, director of the Max Planck Institute for Molecular Biomedicine in Munster, Germany, at an international scientific symposium on stem cell research in Kobe, Japan.
Aptilon Corporation ("Aptilon" or the "Corporation") (TSX-V: APZ), a leading provider of physician access through its innovative alternative sales and marketing channel, today announced that it has acquired from Direct Medical Data, LLC ("DMD"), of Illinois, and BLM Incorporated ("BLM"), of Illinois, substantially all DMD and BLM assets related to their healthcare marketing services (the "Purchased Assets").
Boston Scientific Corporation today announced comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS Liberte Paclitaxel-Eluting Stent System in a variety of lesions and patient groups.
Groundbreaking research from the University of Alberta and McGill University has opened the door towards the future prevention of cardiac fibrosis—a condition leading to heart failure for which there is currently no treatment.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Neal Renn Trulock, 2750 Broadway St, Boulder, CO 80304-3586 Ph: (303) 938-4710 | Neal Renn Trulock, 4745 Arapahoe Ave Ste 200, Boulder, CO 80303-1082 Ph: (303) 938-4710 |
News Archive
Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered that the presence and integrity of the opioid growth factor receptor (OGFr), which mediates the inhibitory action of opioid growth factor (OGF) on cell proliferation, is a key to understanding the progression and treatment of human ovarian cancer.
"Once we have found the factors by which body cells can be re-programmed into stem cells, then therapeutic cloning might become superfluous," said Hans R. Scholer, director of the Max Planck Institute for Molecular Biomedicine in Munster, Germany, at an international scientific symposium on stem cell research in Kobe, Japan.
Aptilon Corporation ("Aptilon" or the "Corporation") (TSX-V: APZ), a leading provider of physician access through its innovative alternative sales and marketing channel, today announced that it has acquired from Direct Medical Data, LLC ("DMD"), of Illinois, and BLM Incorporated ("BLM"), of Illinois, substantially all DMD and BLM assets related to their healthcare marketing services (the "Purchased Assets").
Boston Scientific Corporation today announced comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS Liberte Paclitaxel-Eluting Stent System in a variety of lesions and patient groups.
Groundbreaking research from the University of Alberta and McGill University has opened the door towards the future prevention of cardiac fibrosis—a condition leading to heart failure for which there is currently no treatment.
› Verified 4 days ago
Diane Anthea Christopher, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4745 Arapahoe Ave, 200, Boulder, CO 80303 Phone: 303-938-4710 | |
Elizabeth W Bush, Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 580 Mohawk Dr, Boulder, CO 80303 Phone: 303-554-5111 | |
Mary A Macsalka, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4745 Arapahoe Ave Ste 110, Boulder, CO 80303 Phone: 303-444-5110 Fax: 303-444-7457 | |
Mr. Joseph Cohen, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 5377 Manhattan Cir Ste 204, Boulder, CO 80303 Phone: 720-273-3568 Fax: 720-612-4271 | |
Breanna Tomlin, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2525 13th St, Boulder, CO 80304 Phone: 303-449-6050 Fax: 720-565-4132 | |
Dr. Heather Brighthoffmeyer, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4745 Arapahoe Ave, Suite 200, Boulder, CO 80303 Phone: 303-938-4710 | |
Christine C Hansen, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4745 Arapahoe Ave Ste 110, Boulder, CO 80303 Phone: 303-444-5110 Fax: 303-444-7457 |